Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Featuring an interview with Dr Jamie E Chaft, including the following topics:
- Case: A man in his early 70s with a 40 to 50 pack-year history of smoking and cT2bN1 squamous cell carcinoma of the lung with PD-L1 60% treated with induction therapy and surgery (00:00)
- Available clinical data with immunotherapy in the neoadjuvant, perioperative and adjuvant settings (07:45)
- Factors in the selection of adjuvant immunotherapy, including circulating tumor DNA (11:39)
- Evolving approaches to management, including systemic therapy, surgery and radiation therapy techniques (19:28)
- Case: A woman in her early 60s with nonmetastatic non-small cell lung cancer (NSCLC) and an EGFR exon 19 deletion who is enrolled in the NeoADAURA study (24:03)
- Importance of clinical trials in the adjuvant setting (33:02)
- Data surrounding treatment in the neoadjuvant setting; key implications of the NeoADAURA study (35:41)
- Case: A man in his late 60s with a history of smoking and Stage III T4N3 NSCLC not otherwise specified with low PD-L1 expression, high tumor mutation burden, microsatellite stability and an STK11 mutation (41:34)
- Selecting patients for the NeoADAURA study treatment approach; deciding between chemoimmunotherapy and chemoradiation therapy (51:01)
CME information and select publications
